English  |  正體中文  |  简体中文  |  總筆數 :2854037  
造訪人次 :  45289793    線上人數 :  1059
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

跳至: [ 中文 ] [ 數字0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
請輸入前幾個字:   

顯示項目 550621-550670 / 2346288 (共46926頁)
<< < 11008 11009 11010 11011 11012 11013 11014 11015 11016 11017 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
亞洲大學 1983 Lipoprotein, lyzosomes, and biliary lipids LaRusso NF;Kawamoto T;Mao SJT;Sewell RB.
東海大學 2011 Lipoprotein-associated phospholipase A 2 interacts with phospholipid vesicles via a surface-disposed hydrophobic α-helix Cao, J.a, Hsu, Y.-H.a, Li, S.b, Woods, V.L.b, Dennis, E.A.
國立臺灣大學 2004 Lipoprotein-X Reduces Ldl Atherogenicity in Primary Biliary Cirrhosis by Preventing Ldl Oxidation 張博淵; 呂紹俊; 蘇大成; 周三芳; 廖朝崧; 李源德; CHANG, PO-YUAN; LU, SHAO-CHUN; SU, TA-CHEN; CHOU, SAN-FANG; LIAU, CHIAU-SUONG; LEE, YUAN-THE
中國醫藥大學 2004 Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation (Po-Yuan Chang); (Shao-Chun Lu); (Ta-Chen Su); (San-Fang Chou); (Wen-Huei Huang); (Joel D. Morrisett); 陳珠璜(Chu-Huang Chen); (Chiau-Suong Liau); 李源德(Yuan-Teh, Lee)
臺大學術典藏 2018-09-10T04:49:21Z Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation Chang, P.-Y. and Lu, S.-C. and Su, T.-C. and Chou, S.-F. and Huang, W.-H. and Morrisett, J.D. and Chen, C.-H. and Liau, C.-S. and Lee, Y.-T.; TA-CHEN SU
臺大學術典藏 2020-02-06T08:11:33Z Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation Chang P.-Y.; SHAO-CHUN LU; Su T.-C.; Chou S.-F.; Huang W.-H.; Morrisett J.D.; Chen C.-H.; Liau C.-S.; Lee Y.-T.; Chang P.-Y.;Shao-Chun Lu;Su T.-C.;Chou S.-F.;Huang W.-H.;Morrisett J.D.;Chen C.-H.;Liau C.-S.;Lee Y.-T.
臺大學術典藏 2020-09-28T02:48:05Z Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation Chang P.-Y.;Lu S.-C.;Ta-Chen Su;Chou S.-F.;Huang W.-H.;Morrisett J.D.;Chen C.-H.;Liau C.-S.;Lee Y.-T.; Chang P.-Y.; Lu S.-C.; TA-CHEN SU; Chou S.-F.; Huang W.-H.; Morrisett J.D.; Chen C.-H.; Liau C.-S.; Lee Y.-T.
臺大學術典藏 2004 Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation Morrisett J.D.; Huang W.-H.; Chou S.-F.; Su T.-C.; Lu S.-C.; PO-YUAN CHANG; Chen C.-H.; Liau C.-S.; Lee Y.-T.
高雄醫學大學 2004 Liposomal doxorubicin 治療引起的肢端紅斑症  薛強文;沈育如;陳國熏 
義守大學 2017-04 Liposomal Encapsulation for Systemic Delivery of Propranolol via Transdermal Iontophoresis Improves Bone Microarchitecture in Ovariectomized Rats Benjamin Teong;Shyh Ming Kuo;Wei-Hsin Tsai;Mei-Ling Ho;Chung-Hwan Chen;Han Hsiang Huang
國家衛生研究院 2018-11 Liposomal irinotecan (nal-IRI) plus 5-FU/LV in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) progressing on gemcitabine-based treatment: Further subgroup analyses of the pivotal NAPOLI-1 study Chen, LT;Mercade, TM;Lee, KH;Lakatos, G;Wang-Gillam, A;Mirakhur, B;de Jong, F
國家衛生研究院 2020-01 Liposomal irinotecan + 5-FU/LV in metastatic pancreatic cancer: Subgroup analyses of patient, tumor, and previous treatment characteristics in the pivotal NAPOLI-1 trial Macarulla Mercade, T;Chen, LT;Li, CP;Siveke, JT;Cunningham, D;Bodoky, G;Blanc, JF;Lee, KH;Dean, A;Belanger, B;Wang-Gillam, A
國立成功大學 2020 Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial MacArulla, Mercad� T.;Chen, L.-T.;Li, C.-P.;Siveke, J.T.;Cunningham, D.;Bodoky, G.;Blanc, J.-F.;Lee, K.-H.;Dean, A.;Belanger, Belanger B.;Wang-Gillam, A.
國家衛生研究院 2019-03-04 Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial Macarulla, T;Blanc, JF;Wang-Gillam, A;Chen, LT;Siveke, JT;Mirakhur, B;Chen, J;de Jong, FA
國立成功大學 2019 Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer – A subgroup analysis of the pivotal NAPOLI-1 trial Macarulla, T.;Blanc, J.-F.;Wang-Gillam, A.;Chen, L.-T.;Siveke, J.T.;Mirakhur, B.;Chen, J.;de, Jong F.A.
國家衛生研究院 2019-12-01 Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study Bang, YJ;Li, CP;Lee, KH;Chiu, CF;Park, JO;Shan, YS;Kim, JS;Chen, JS;Shim, HJ;Rau, KM;Choi, HJ;Oh, DY;Belanger, B;Chen, LT
國立成功大學 2020 Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study Bang, Y.-J.;Li, C.-P.;Lee, K.-H.;Chiu, Chiu C.-F.;Park, J.O.;Shan, Y.-S.;Kim, J.S.;Chen, J.-S.;Shim, H.-J.;Rau, K.-M.;Choi, H.J.;Oh, D.-Y.;Belanger, Belanger B.;Chen, L.-T.
中山醫學大學 2021 Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients' experience within a population-based study Chiu, TJ; Su, YY; Yang, SH; Li, CP; Bai, LY; Chiang, NJ; Chuang, SC; Shan, YS; Chan, DC; Chen, LT; Yen, CJ; Peng, CM; Chen, YY; Chen, JS; Chou, WC
國家衛生研究院 2021-11-20 Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study Chiu, TJ;Su, YY;Yang, SH;Li, CP;Bai, LY;Chiang, NJ;Chuang, SC;Shan, YS;Chan, DC;Chen, LT;Yen, CJ;Peng, CM;Chen, YY;Chen, JS;Chou, WC
國立成功大學 2021 Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study Chiu, T.-J.;Su, Y.-Y.;Yang, S.-H.;Li, C.-P.;Bai, L.-Y.;Chiang, N.-J.;Chuang, S.-C.;Shan, Y.-S.;Chan, D.-C.;Chen, L.-T.;Yen, C.-J.;Peng, C.-M.;Chen, Y.-Y.;Chen, J.-S.;Chou, W.-C.
臺大學術典藏 2022-03-08T03:44:01Z Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients�� experience within a population-based study Chiu T.-J.; Su Y.-Y.; SHIH-HUNG YANG; Li C.-P.; Bai L.-Y.; Chiang N.-J.; Chuang S.-C.; Shan Y.-S.; Chan D.-C.; Chen L.-T.; Yen C.-J.; Peng C.-M.; Chen Y.-Y.; Chen J.-S.; Chou W.-C.
中山醫學大學 2016 Liposomal n-butylidenephthalide protects the drug from oxidation and enhances its antitumor effects in glioblastoma multiforme YL, Lin; KF, Chang; XF, Huang; CL, Hung; SC, Chen; WR, Chao; KW, Liao; NM, Tsai
國立交通大學 2019-04-03T06:35:34Z Liposomal n-butylidenephthalide protects the drug from oxidation and enhances its antitumor effects in glioblastoma multiforme Lin, Yu-Ling; Chang, Kai-Fu; Huang, Xiao-Fan; Hung, Che-Lun; Chen, Shyh-Chang; Chao, Wan-Ru; Liao, Kuang-Wen; Tsai, Nu-Man
臺大學術典藏 2021-07-07T02:12:42Z Liposomal paclitaxel induces fewer hematopoietic and cardiovascular complications than bioequivalent doses of Taxol Huang S.-T.; YI-PING WANG; Chen Y.-H.; Lin C.-T.; Li W.-S.; Wu H.-C.
臺大學術典藏 2022-03-04T06:10:52Z Liposomal paclitaxel induces fewer hematopoietic and cardiovascular complications than bioequivalent doses of Taxol Huang S.-T.; Wang Y.-P.; Chen Y.-H.; CHIN-TARNG LIN; Li W.-S.; Wu H.-C.
國家衛生研究院 2020-03-28 Liposomal TLR9 agonist combined with TLR2 agonist-fused antigen can modulate tumor microenvironment through dendritic cells Shen, KY;Liu, HY;Yan, WL;Wu, CC;Lee, MH;Leng, CH;Liu, SJ
臺大學術典藏 2019-07-23T01:51:04Z Liposomal vesicles-protein interaction: Influences of iron liposomes on emulsifying properties of whey protein Li, Li;MIN-HSIUNG PAN;Zheng, Quanhui;Wei, Shudong;Ding, Baomiao;YANG-FANG CHEN;Chiou, Yi shiou;Li, Zhenshun;Hu, Jie;Yi, Xiangzhou;Duan, Shengzhou; Duan, Shengzhou; Yi, Xiangzhou; Hu, Jie; Li, Zhenshun; Chiou, Yi shiou; YANG-FANG CHEN; Ding, Baomiao; Wei, Shudong; Zheng, Quanhui; MIN-HSIUNG PAN; Li, Li
臺大學術典藏 2021-06-22T02:01:33Z Liposomal vesicles-protein interaction: Influences of iron liposomes on emulsifying properties of whey protein Yi, X.;Zheng, Q.;Pan, M.-H.;Chiou, Y.-S.;Li, Z.;Li, L.;Chen, Y.;Hu, J.;Duan, S.;Wei, S.;Ding, B.; Yi, X.; Zheng, Q.; Pan, M.-H.; Chiou, Y.-S.; Li, Z.; Li, L.; Chen, Y.; Hu, J.; Duan, S.; Wei, S.; Ding, B.; MIN-HSIUNG PAN
中國醫藥大學 2005-12-15 Liposome as a Drug Carrier in Inhibiting Smooth Muscle Cell Proliferation (Ching-Yun Chen); 陳語謙; 吳介信(副教授); 陳悅生
臺北醫學大學 2006 Liposome Composition for Delivery of a Therapeutic Agent to Eye 劉俊仁; Liu; J.J.Tseng; Y.L; Guo; L.Hong; K.
中國醫藥大學 2007-03-18 LIPOSOME ENCAPSULATED MAGNOLOL AS A DRUG CARRIER IN INHIBITING SMOOTH MUSCLE CELL PROLIFERATION (W.C Lee); (Y.J Chen); 陳語謙(Chen, Yu-Chian); (C.H Wu)
臺北醫學大學 2008 Liposome encapsulation reduces cantharidin toxicity 劉得任; Liu DZ; Chang CC; Lin SY; Liang HJ; Hou WC; Liang YC
臺北醫學大學 2008 Liposome encapsulation reduces cantharidin toxicity 黃偉展; Chang CC; Liu DZ; Lin SY; Liang HJ; Hou WC; Huang WJ; Chang CH; Ho FM; Liang YC
元培科技大學 2008 Liposome encapsulation reduces cantharidin toxicity Chun-Chao Chang; Der-Zen Liu; Shyr-Yi Lin; Hong-Jen Liang; Wen-Chi Hou; Wei-Jan Huang; Chih-Hsiang Chang; Feng-Ming Ho; and Yu-Chih Liang
臺北醫學大學 2008 Liposome encapsulation reduces cantharidin toxicity. 梁有志; Chang CC; Liu DZ; Lin SY; Liang HJ; Hou WC; Huang WJ; Chang CH; Ho FM; Liang YC.
臺大學術典藏 2018-09-10T08:10:04Z Liposome-based immunoaffinity chromatographic assay for the quantitation of immunoglobulin E in human serum Annie Ho, J.-a.; Wu, L.-C.; Chang, L.-H.; Hwang, K.-C.; Reuben Hwu, J.-R.; JA-AN ANNIE HO
國立暨南國際大學 2010 Liposome-based immunoaffinity chromatographic assay for the quantitation of immunoglobulin E in human serum? 吳立真; Wu, LC
臺大學術典藏 2008 Liposome-based immunostrip for the rapid detection of Salmonella Ho, Ja-An Annie; Zeng, Shi-Chin; Tseng, Wei-Hsiang; Lin, Yong-Jen; Chen, Chun-Hsien; Ho, Ja-an Annie; Zeng, Shi-Chin; Tseng, Wei-Hsiang; Lin, Yong-Jen; Chen, Chun-hsien
國立臺灣大學 2008 Liposome-based immunostrip for the rapid detection of Salmonella Ho, Ja-an Annie; Zeng, Shi-Chin; Tseng, Wei-Hsiang; Lin, Yong-Jen; Chen, Chun-hsien
國立暨南國際大學 2004 Liposome-based microcapillary immunosensor for detection of Escherichia coli O157 : H7 許秀雯?; Hsu, HW
國立暨南國際大學 2004 Liposome-based microcapillary immunosensor for detection of Escherichia coli O157 : H8 黃明瑞?; Huang, MR
國立暨南國際大學 2004 Liposome-based microcapillary immunosensor for detection of Escherichia coli O157 : H9 何佳安?; Ho, JAA
臺大學術典藏 2018-09-10T04:49:10Z Liposome-based microcapillary immunosensor for detection of Escherichia coli O157:H7 Ho, J.-A.A.;Hsu, H.-W.;Huang, M.-R.; Ho, J.-A.A.; Hsu, H.-W.; Huang, M.-R.; JA-AN ANNIE HO
國家衛生研究院 2012-02 Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switch Chen, C;Lin, Y;Liu, Y;He, P;Lin, C;Chiu, Y;Wu, C;Cheng, T;Liu, S;Liao, K
國立交通大學 2014-12-08T15:23:02Z Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switch Chen, Chia-Hung; Lin, Yu-Ling; Liu, Yen-Ku; He, Pei-Juin; Lin, Ching-Min; Chiu, Yi-Han; Wu, Chang-Jer; Cheng, Tian-Lu; Liu, Shih-Jen; Liao, Kuang-Wen
國立臺灣海洋大學 2012 Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switch Chia-Hung Chen; Yu-Ling Lin; Yen-Ku Liu; Pei-Juin He; Ching-Min Lin; Yi-Han Chiu; Chang-Jer Wu; Tian-Lu Cheng; Shih-Jen Liu; Kuang-Wen Liao
中國醫藥大學 2012-02 Liposome-based Polymer Complex as a Novel Adjuvant: Enhancement of Specific Antibody Production and Isotype Switch 陳家宏(Chia-Hung Chen);(Yu-Ling Lin);(Yen-Ku Liu);(Pei-Juin He);(Ching-Min Lin);(Yi-Han Chiu);吳彰哲(Chang-Jer Wu);鄭添祿(Tian-Lu Cheng);劉士任(Shih-Jen Liu)*;廖光文(Kuang-Wen Liao)*
國立臺灣大學 1988 Liposome-Bound Cyclosporine: Retinal Toxicity after Intravitreal Injection 劉寬鎔; ALGHADYAN ABDULRAHMAN A; PEYMAN GHOLAM A.; KHOOBEHI BAHRAM; LIU, KUAN-RONG
國立臺灣大學 1988 Liposome-bound Cyclosporine:Aqueous and Vitreous Level After Subconjunctival Injection Alghadyan, A. A.; Peyman, G. A.; Khoobehi, B.; Milner, S.; 劉寬鎔; Alghadyan, A. A.; Peyman, G. A.; Khoobehi, B.; Milner, S.; Liu, Kwan-Rong
義守大學 2014-05 Liposome-encapsulated cinnamaldehyde enhances zebrafish (Danio rerio) immunity and survival when challenged with Vibrio vulnificus and Streptococcus agalactiae Elok Ning Faikoh;Yong-Han Hong;Shao-Yang Hu

顯示項目 550621-550670 / 2346288 (共46926頁)
<< < 11008 11009 11010 11011 11012 11013 11014 11015 11016 11017 > >>
每頁顯示[10|25|50]項目